Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AMGN
AMGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AMGN News
Repatha Significantly Reduces CV Event Risk in High-Risk Patients
1d ago
PRnewswire
Repatha Significantly Reduces Cardiovascular Event Risk in High-Risk Patients
1d ago
Newsfilter
Repatha Significantly Reduces Cardiovascular Event Risk in High-Risk Patients
1d ago
Yahoo Finance
EMA's CHMP Suggests Expanding Therapeutic Use for Hympavzi
3d ago
moomoo
EMA's CHMP Reaffirms Decision to Deny Change in Marketing Authorization for Hetlioz (Tasimelteon)
3d ago
moomoo
Anthropic: A Standout Innovator in AI
Mar 20 2026
Fool
Anthropic's Rise in the AI Landscape
Mar 20 2026
NASDAQ.COM
Novo Nordisk's High-Dose Wegovy Approved by FDA
Mar 19 2026
CNBC
Strong Dividend ETF Recommendation
Mar 15 2026
Fool
Strong Performance of Health-Focused Dividend ETF
Mar 15 2026
NASDAQ.COM
Amgen and GSK Join TrumpRx Drug Sales Platform
Mar 14 2026
seekingalpha
GSK and Amgen Expand TrumpRx with New Medications - Fox Business
Mar 13 2026
moomoo
Income Fund Excels Thanks to Stocks Like Starbucks, Amgen, and CVS
Mar 12 2026
Barron's
Investment Opportunities in Biotech Stocks
Mar 09 2026
CNBC
Intensifying Competition in Weight Loss Drug Market
Mar 08 2026
Fool
Novo Nordisk vs. Amgen: Weight Loss Drug Competition
Mar 08 2026
NASDAQ.COM
Show More News
